Advertisement

Topics

Durvalumab Results Spark Hope for Progress in Advanced NSCLC

12:14 EDT 16 Apr 2019 | OncLive

During an OncLive Peer Exchange® discussion, moderator Mark A. Socinski, MD, and other lung cancer experts from across the United States discuss what, in this context, the PACIFIC trial results mean for practicing oncologists and their patients. 

Original Article: Durvalumab Results Spark Hope for Progress in Advanced NSCLC

NEXT ARTICLE

More From BioPortfolio on "Durvalumab Results Spark Hope for Progress in Advanced NSCLC"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...